Nav: Home

Aspirin fights gum disease too: new study

February 29, 2000

A world-first study by Australian dental researchers has discovered a link between taking aspirin and protection against gum disease.

The study, by Dr Arthur Drouganis and Dr Robert Hirsch at Adelaide University's Dental School, shows that even ex-smokers can benefit from small doses of aspirin.

Gum disease is a major problem in Australia, with an estimated 10% of the population suffering from its most severe form, known as periodontitis. The problem particularly affects smokers and ex-smokers.

Periodontitis causes deterioration of the structures in the gums that hold the teeth in place. This can result in the teeth falling out.

In the first study of its kind, Dr Drouganis and Dr Hirsch investigated the dental health of 392 Adelaide men who were ex- or non-smokers. (Men were chosen for the study because mature-aged women can be affected by hormonal changes which can influence the health of the gums.) The study found that men aged 50 and above who were taking low doses of aspirin to prevent heart attacks, strokes and other vascular diseases, had significantly better gum health than those who did not take aspirin.

Non-smokers were better off than ex-smokers, which confirmed the already well-documented findings that smoking has a negative effect on gum health. (Smokers also have fewer teeth at a given age than non-smokers, with ex-smokers being in the middle of the range.)

The implications of these findings are that low doses of aspirin may protect the fibres and ligaments that attach the gums to the teeth. This is possibly because aspirin inhibits the action of prostaglandin E2, a chemical messenger that triggers bone loss in severe gum disease.

"Our findings show that people aged over 50, particularly ex-smokers and probably smokers, may reduce their risk of deteriorating gums by taking low doses of aspirin (100mg) daily," Dr Drouganis says.

He says an important distinction needs to be drawn between superficial gum inflammation, known as gingivitis, and severe gum disease or periodontitis.

"People might think that if they have bleeding gums, the most common symptom of any gum disease, they might benefit from taking aspirin. They certainly wouldn't," he says.

"Only those people who have a history of severe gum disease would benefit from low doses of aspirin, and they may be identified by their dentist or periodontist. They should, of course, discuss this with their doctor to avoid interference with other medications or medical conditions."
-end-
Photos are available at http://www.adelaide.edu.au/media_photos/

MEDIA CONTACT:

Dr Arthur Drouganis: (08) 8272 8550 work
(08) 8344 8779 home
0418 848 500 mobile
adro@senet.com.au

University of Adelaide

Related Aspirin Articles:

Switching to aspirin/clopidogrel following 1 month of new P2Y12 inhibitor/aspirin post-ACS
Paris, France: Switching to a fixed-dose combination of aspirin plus clopidogrel after one month of potent dual antiplatelet therapy (DAPT) with a new P2Y12 inhibitor plus aspirin following an acute coronary syndrome (ACS) treated with a percutaneous coronary intervention (PCI) is associated with reduced risk of bleeding complications with no increase in ischaemic events, showed results from a study reported at EuroPCR 2017.
An alternative theory on how aspirin may thwart cancer
Many studies have pointed to a role for aspirin in cancer prevention.
New 'Aspirin-Guide' app for clinicians helps personalize decisions about aspirin use
To help clinicians and patients make informed decisions about aspirin use, researchers at Brigham and Women's Hospital have developed a new, free, mobile app, 'Aspirin-Guide' that calculates both the CVD risk score and the bleeding risk score for the individual patient, and helps clinicians decide which patients are appropriate candidates for the use of low-dose aspirin.
Aspirin may help prevent bile duct cancer
Regular use of aspirin was linked with a significantly reduced risk of developing bile duct cancer, also called cholangiocarcinoma, in a recent study.
Taking aspirin could increase cancer survival by 20 percent
Patients receiving cancer treatment could increase their chance of survival by up to 20 percent and help stop their cancer from spreading by taking a low dose of aspirin, new research suggests.
Pre-exposure prophylaxis (PrEP) as safe as aspirin
UCLA researchers reviewed major studies of both PrEP for HIV prevention and aspirin for heart attack prevention.
Possible new mechanism for aspirin's role in cancer prevention
In a study published in the journal of Cancer Epidemiology, Biomarkers, and Prevention, Cornelia Ulrich from Huntsman Cancer Institute and her collaborators used a new technique, metabolite profiling, to identify a biochemical pathway previously unknown to be regulated by aspirin.
Take 2 aspirin and make sure you're not allergic
Some patients who have a reaction to aspirin are told they are allergic without being tested by an allergist, and stop an otherwise effective therapy.
Could aspirin treat breast cancer?
Researchers from Brigham and Women's Hospital and Dana-Farber Cancer Institute will test if aspirin helps women with breast cancer avoid recurrence and live longer.
Aspirin reverses obesity cancer risk
Research has shown that a regular dose of aspirin reduces the long-term risk of cancer in those who are overweight in an international study of people with a family history of the disease.

Related Aspirin Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...